Unlocking Upstream Value: Donor-to-Dose Solutions for Scalable Cell Therapy Manufacturing

Cell therapy success starts upstream. From donor variability to manufacturing scalability, the quality of your starting material defines the potency and reliability of every dose.

Access the recording to explore:

• Tackling donor variability for more predictable outcomes
  
• Gentle, next-gen cell separation to maximize therapeutic potency
• Integrated platforms that streamline workflows and improve scalability
• How partnerships across the CGT ecosystem accelerate delivery to patients

Discover how cell separation, donor sourcing, apheresis, and automation are transforming workflows to drive efficiency, consistency, and reduced COGS.

Speakers:

	Dr. Bill Lloyd Sr. Director of R&D Akadeum Life Sciences
	Dr. Robert Tressler CSO and Co-Founder Excellos
	Kathleen Zohorsky Senior Scientist and Team Lead Lonza